This is the first report showing PSA as a useful biomarker for predicting prognosis at levels between 20 and 70 ng / mL, whereas PSA could not be a prognostic factor in patients with PCa and PSA levels of ≥ 70 ng / mL. This evidence concerns the gene KLK3 and posterior cortical atrophy.